- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01404273
Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
July 29, 2013 updated by: George Bush, Massachusetts General Hospital
Functional MRI of an Open Trial of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder
This research study is being done to examine how meditation and the relaxation response (RR) may change brain activity in attention-deficit/hyperactivity disorder (ADHD).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Benson-Henry Institute, 151 Merrimac St, 4th Floor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 49 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female adults (ages 18 - 49).
- Patients with the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), by the Diagnostic and Statistics Manual of Mental Disorders (DSM-IV), as manifested in clinical evaluation and confirmed by structured interview.
Exclusion Criteria:
- Any current, non-ADHD Axis I psychiatric conditions
- Baseline Beck Depression Inventory (BDI) > 19.
- Any clinically significant chronic medical condition.
- Mental retardation
- Organic brain disorders
- Seizures or tics.
- Pregnant or nursing females.
- Clinically unstable psychiatric conditions (suicidal behaviors, psychosis).
- Current or recent (within the past 2 years) substance abuse or dependence.
- Patients currently or recently (within past 1 month) on psychotropic medication.
- Subjects with current or prior adequate psychopharmacologic treatment for ADHD.
- Regular practice of an Relaxation Response-inducing technique within the past year
- History of claustrophobia or any of the standard contraindications to magnetic resonance imaging (MRI) scanning(metal objects within body).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Meditation/Relaxation Response Training
|
1 hour weekly sessions with 20 min daily home practice for 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in functional magnetic resonance imaging (fMRI) activation from baseline after a 6-week intervention
Time Frame: 2 sessions, 2 hours each to be conducted before and after the 6-week intervention
|
functional magnetic resonance imaging (fMRI) activation in dorsal anterior medial cingulate cortex (daMCC) & dorsolateral prefrontal cortex (DLPFC) during multi-source interference task (MSIT)
|
2 sessions, 2 hours each to be conducted before and after the 6-week intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: George Bush, M.D., MGH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
July 25, 2011
First Submitted That Met QC Criteria
July 26, 2011
First Posted (Estimate)
July 28, 2011
Study Record Updates
Last Update Posted (Estimate)
July 31, 2013
Last Update Submitted That Met QC Criteria
July 29, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2009P002052
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
Okinawa Institute of Science and Technology Graduate...Japan society for the promotion of science; Miyazaki International CollegeRecruiting
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting
-
Universidad de GranadaNot yet recruiting
-
Izmir Katip Celebi UniversityDokuz Eylul UniversityNot yet recruiting
-
Seattle Children's HospitalNational Institute of Mental Health (NIMH); University of WashingtonRecruiting
-
University of California, DavisRecruiting
-
Chen LiRecruiting
-
Region SyddanmarkRecruiting
-
Hugo W. Moser Research Institute at Kennedy Krieger...Active, not recruiting
Clinical Trials on Meditation/Relaxation Response Training
-
Massachusetts General HospitalBrigham and Women's HospitalCompleted
-
University of Sao PauloCompleted
-
William Beaumont Army Medical CenterTerminatedPosttraumatic Stress DisorderUnited States
-
Allina Health SystemWithdrawnBurnout | Resilience | Perceived StressUnited States
-
Beth Israel Deaconess Medical CenterCenters for Disease Control and PreventionCompleted
-
Mayo ClinicTerminated
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH)CompletedSomatoform Disorders | HypochondriasisUnited States
-
Ningbo Medical Center Lihuili HospitalCompletedHemodialysis Patients With SarcopeniaChina
-
University of California, Los AngelesCompletedMajor Depressive Disorder | Depression NOS | Anxiety NOSUnited States